ATRIAL-NATRIURETIC-PEPTIDE INHIBITS THE EXPRESSION OF TISSUE FACTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 INDUCED BY ANGIOTENSIN-II IN CULTURED RAT AORTIC ENDOTHELIAL-CELLS
M. Yoshizumi et al., ATRIAL-NATRIURETIC-PEPTIDE INHIBITS THE EXPRESSION OF TISSUE FACTOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 INDUCED BY ANGIOTENSIN-II IN CULTURED RAT AORTIC ENDOTHELIAL-CELLS, Thrombosis and haemostasis, 79(3), 1998, pp. 631-634
The pharmacological characteristics of atrial natriuretic peptide (ANP
), such as natriuresis, vasodilation, or suppression of smooth muscle
cell proliferation, are well investigated. However, this is the first
study to report its role on blood coagulation and fibrinolysis mediate
d by vascular endothelial cells. In this study, the effects of ANP on
the enhanced expression of tissue factor (TF) and plasminogen activato
r inhibitor 1 (PAI-1) by angiotensin II (Ang II) in cultured rat aorti
c endothelial cells (RAECs) were examined. The expressions of TF and P
AI-1 mRNA were detected by northern blotting methods. The activities o
f TF on the surface of RAECs and PAI-1 in the culture media were measu
red by chromogenic assay. ANP suppressed mRNA expressions of TF and PA
I-1 induced by Ang II in a concentration-dependent manner. This suppre
ssion was accompanied by the decreased activities of TF and PAI-1.